Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J. Wallace, Claire Andrejak, Erik C. Böttger, Jan Brozek, David E. Griffith, Lorenzo Guglielmetti, Gwen A. Huitt, Shandra L. Knight, Philip Leitman, Theodore K. Marras, Kenneth N. Olivier, Miguel Santin, Jason E. Stout, Enrico Tortoli, Jakko van Ingen, Dirk Wagner, Kevin L. Winthrop. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020

Member's Comments

No comment yet.

Related content which might interest you: Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement Source: Eur Respir J, 51 (3) 1800170; 10.1183/13993003.00170-2018 Year: 2018 New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Source: Virtual Congress 2020 – German programme 2020 Year: 2020 Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases Source: Eur Respir J , 49 (2) 1601855; DOI: 10.1183/13993003.01855-2016 Year: 2017 The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease Source: Eur Respir Monogr 2018; 81: 204-221 Year: 2018 New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Year: 2020 Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease Source: Eur Respir J, 53 (5) 1801636; 10.1183/13993003.01636-2018 Year: 2019 Stricter microbiological criteria are useful surrogate in estimating the prevalence of nontuberculous mycobacterial pulmonary disease in Croatia Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017 Year: 2017 Identification and management of non tuberculous mycobacteria in extra pulmonary cases in clinical practice Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management Source: Guideline 2016 Year: 2016 Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management Source: Eur Respir J 2016; 47: 45-68 Year: 2016 An expert statment on clinical considerations before treating NTM lung infection Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections Year: 2020 Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Clinical analysisof patients with pulmonary nontuberculous mycobacterial disease complicated with pneumothorax Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis Source: Eur Respir J 2016; 48: 963-971 Year: 2016 Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020